CHICAGO--(BUSINESS WIRE)--Fitch Ratings has assigned a ‘BBB-' rating to Watson Pharmaceuticals, Inc.'s (Watson) (NYSE: WPI) proposed offering of up to $850 million in new five- and 10-year senior unsecured notes. In addition, Fitch has affirmed Watson’s ratings as follows:
